ÂÜÀòÂÒÂ×

Colleen Doyle Cooper is currently the Chief Scientific Officer at Aclys Bio, with previous roles as Principal Scientist at Celdara Medical, Lead Scientist at Javelin Oncology, Staff Scientist at VGTI Florida, Research Associate at The Scripps Research Institute, and Graduate Student at The University of Chicago. Colleen holds a Doctor of Philosophy (PhD) in Microbiological Sciences and Immunology from The Scripps Research Institute and a Bachelor of Science (B.S.) in Biology from The University of Michigan. Additionally, Colleen has obtained two Doctor of Philosophy (PhD) degrees from The University of Chicago Pritzker School of Medicine and University of Chicago.